Xanthoxyletin blocks the RANK/RANKL signaling pathway to suppress the growth of human pancreatic cancer cells Cover

.blurhash-client-img { display: none !important; }

Xanthoxyletin blocks the RANK/RANKL signaling pathway to suppress the growth of human pancreatic cancer cells

Acta Pharmaceutica

Volume 73 (2023): Issue 3 (September 2023)

By: Xin Zhang, Luming Li and Yan Wu

Open Access

|Sep 2023

Authors

Xin Zhang

Department of General Medicine The First People’s Hospital of Lianyungang, Lianyungang, China

Luming Li

Department of Neurology, The First People’s Hospital of Lianyungang Lianyungang, Jiangsu, China

Yan Wu

yanwu959@gmail.com

Department of General Medicine The First People’s Hospital of Lianyungang, Lianyungang, China

DOI: https://doi.org/10.2478/acph-2023-0024 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075

Journal RSS Feed

Language: English

Page range: 503 - 513

Accepted on: Mar 20, 2023

|

Published on: Sep 14, 2023

Published by: Croatian Pharmaceutical Society

In partnership with: Paradigm Publishing Services

Publication frequency: 4 issues per year

Keywords:

pancreatic cancer,

Related subjects:

Pharmacy, other

© 2023 Xin Zhang, Luming Li, Yan Wu, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous article Volume 73 (2023): Issue 3 (September 2023)